PanTheryx Announces Major Financing by Pegasus Capital Advisors
Enhances Financial and Advisory Resources for Key Growth Initiatives
BOULDER, Colo.–(BUSINESS WIRE)–PanTheryx,
Inc. (“PanTheryx”), a global medical nutrition company based in Boulder,
Colorado, announced today that it has entered into a $53 million
financing with Pegasus
Capital Advisors, L.P. (“Pegasus” or the “Firm”). PanTheryx will use
the proceeds to support the global commercial launch of its infectious
diarrhea product, DiaResQ®,
to aggressively drive its ongoing research and development program, and
for other strategic initiatives including acquisitions. Terms of the
transaction were not disclosed.
Pegasus is a private equity firm founded and led by Craig Cogut. Since
inception in 1996, Pegasus has invested across five private equity funds
and currently manages approximately $1.8 billion in assets. The Firm’s
principal investment theme is providing strategic growth capital to
companies within the middle-market focused on global resource scarcity,
particularly energy, waste, food, water and health & wellness.
PanTheryx is dedicated to improving global health through the
development and commercialization of medical nutrition products that
target the gastrointestinal microbiome. The company’s flagship product, DiaResQ®,
addresses acute infectious diarrhea, a leading cause of death worldwide
among children under the age of five. It was recently named in the Reimagining
Global Health report as one of the 30
leading healthcare innovations with great promise to transform
global health by 2030 and to help accelerate progress toward new health
targets proposed in the United Nations Sustainable Development Goals.
As a Pegasus portfolio company, PanTheryx will have access to Pegasus’
operating advisors, a diverse and specialized team of differentiated
business and health science experts, who will provide PanTheryx
management with unbiased counsel, expansive thinking and access to new
global relationships.
“With its seasoned and talented management team and innovative,
proprietary technology, PanTheryx was an ideal addition to our
sustainable living portfolio” said Craig Cogut, Pegasus Chairman and
President. “We view PanTheryx as the cornerstone of our life sciences
and microbiome strategy and a platform through which we can partner with
other innovative companies that are reimagining traditional approaches
to health and wellness.”
Said Mark A. Braman, President and CEO of PanTheryx, “It became evident
from our very first meeting with the Pegasus team that we shared a
common passion for the vast potential of nutrition driven interventions
to solve major global health issues. This alignment of vision and
mission made Pegasus the ideal strategic partner for us.”
This announcement follows several recent milestones for the company. Dr.
Mark Grabowsky, a global health expert in disease prevention and child
health, joined the company in December to direct expanding relationships
with U.S. health agencies, foreign ministries of health and
nongovernment organizations. This past September, PanTheryx announced a
multi-country supply and licensing agreement with Dr.
Reddy’s Laboratories Ltd. (NYSE: RDY), a leading global
pharmaceutical company.
DiaResQ® is now available in the United States on Amazon.com
and at Passport
Health clinics throughout the country.
About PanTheryx:
Founded in 2007, PanTheryx is a global medical nutrition company based
in Boulder, Colorado, and is dedicated to improving global health and
quality of life through innovative life science. Utilizing its
broad-based proprietary technology platform, PanTheryx is focused on the
development and commercialization of medical nutrition products that
target the gastrointestinal microbiome. The company’s lead product
addresses acute infectious diarrhea, a leading cause of death worldwide
among children under the age of five. For more information, log on to: www.pantheryx.com
and www.diaresq.com.
About Pegasus Capital Advisors:
Pegasus is a private equity firm founded and led by Craig Cogut. Since
inception in 1996, Pegasus has invested across five private equity funds
and currently manages approximately $1.8 billion in assets. The Firm’s
principal investment theme is providing strategic growth capital to
companies within the middle-market focused on global resource scarcity,
particularly energy, waste, food, water and health & wellness.
Contacts
PanTheryx, Inc
Rodney D Bell, 303-807-3397
Rbell at
pantheryx.com
or
Amy Fletcher, 720-350-3144
Info at
afmcommunications.com
